Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Bread Wheat Genome Sequenced

Growing wheat

An international collaboration published a complete, annotated genomic sequencing of wheat used in making bread, a widely grown staple crop and major source of nutrition worldwide. . . . → Read More: Bread Wheat Genome Sequenced

Pfizer, Biotech Partner on RNA Flu Vaccine

3-D print of influenza virus

A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine

Peptide Pain Drugs in Development Aimed at Alternative Targets

Neuron

Pain drugs made from peptides, small protein-like compounds, and guided by antibodies are being developed as alternatives to prescription opioids to treat moderate to severe pain. . . . → Read More: Peptide Pain Drugs in Development Aimed at Alternative Targets

FDA Approves RNA-Interference Nerve Disease Therapy

Onpattro

A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration. . . . → Read More: FDA Approves RNA-Interference Nerve Disease Therapy

Cancer Drug Delivery Through Milk Particles Under Study

Cattle

A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions. . . . → Read More: Cancer Drug Delivery Through Milk Particles Under Study

Start-Up Developing Regenerative Liver Disease Treatments

Damaged liver cells

A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments

Allergan Licensing Crispr for Inherited Eye Disease

Editing DNA

Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease

Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

T-cells illustration

Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

Engineered Bacteria Studied for Rare Inherited Skin Disorder

f Staphylococcus epidermidis

A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children. . . . → Read More: Engineered Bacteria Studied for Rare Inherited Skin Disorder

Trial Shows Antibiotic More Effective Against Crohn’s Disease

Cattle

Early results from a clinical trial show an experimental antibiotic drug helps more people achieve remission of their Crohn’s disease for longer periods than a similar group given a placebo. . . . → Read More: Trial Shows Antibiotic More Effective Against Crohn’s Disease